Sangamo Therapeutics, Inc.
SGMO
$0.6565
$0.03425.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.40M | 10.67M | -36.13M | -49.09M | -60.30M |
| Total Depreciation and Amortization | 2.14M | 2.13M | 2.57M | 2.53M | 3.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.57M | 3.43M | 4.13M | 6.80M | 5.97M |
| Change in Net Operating Assets | 15.34M | -4.47M | 2.54M | -8.90M | 783.00K |
| Cash from Operations | -3.35M | 11.76M | -26.88M | -48.66M | -50.54M |
| Capital Expenditure | -152.00K | -115.00K | -- | -- | -2.67M |
| Sale of Property, Plant, and Equipment | 1.48M | 348.00K | 127.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 35.84M | 40.38M |
| Cash from Investing | 1.32M | 233.00K | 127.00K | 35.84M | 37.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.21M | 0.00 | -- | 22.52M | 216.00K |
| Repurchase of Common Stock | -220.00K | -203.00K | -533.00K | -402.00K | -49.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.99M | -203.00K | -533.00K | 22.12M | 167.00K |
| Foreign Exchange rate Adjustments | -2.25M | 1.13M | -257.00K | -670.00K | 1.35M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.72M | 12.92M | -27.55M | 8.63M | -11.31M |
